Financhill
Buy
51

VITOF Quote, Financials, Valuation and Earnings

Last price:
$0.66
Seasonality move :
694.91%
Day range:
$0.66 - $0.66
52-week range:
$0.65 - $1.00
Dividend yield:
0%
P/E ratio:
2.35x
P/S ratio:
0.99x
P/B ratio:
0.46x
Volume:
--
Avg. volume:
--
1-year change:
-34%
Market cap:
$310.2M
Revenue:
$310.7M
EPS (TTM):
--

Earnings Data

Next earnings date for VITOF
--
Most recent earnings per share
$0.09
Beat by $0.09
(Dec 31/2023)
Consensus Estimate
--
(Dec 31/2023)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VITOF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2023 Q4 -- -$1.5B $0.09 -- --
09/30/2023 Q3 -- $625.7M $0.03 -- --
06/30/2023 Q2 -- $622M $0.08 -- --
03/31/2023 Q1 -- $602.1M $0.08 -- --
12/31/2022 Q4 -- -$1.5B $0.02 -- --
09/30/2022 Q3 -- $622.9M -$0.03 -- --
06/30/2022 Q2 -- $581M $0.02 -- --
03/31/2022 Q1 -- $552.4M $0.04 -- --
12/31/2021 Q4 -- $511.5M -$0.20 -- --
09/30/2021 Q3 -- $491.3M -$0.01 -- --
06/30/2021 Q2 -- $480.5M -$0.02 -- --
03/31/2021 Q1 $470.1M $474.4M -$0.01 -- --
12/31/2020 Q4 $444M $493.3M -$0.28 -- --
09/30/2020 Q3 $455.9M $476M $0.03 -- --
06/30/2020 Q2 -- $299M -$0.13 -- --
03/31/2020 Q1 -- $500M $0.28 -- --
12/31/2019 Q4 -- $504.9M -$0.08 -- --
09/30/2019 Q3 -- $554.4M $0.08 -- --
06/30/2019 Q2 -- $565.6M $0.08 -- --
03/31/2019 Q1 -- $555M $0.05 -- --
12/31/2018 Q4 -- $540.4M $0.04 -- --
09/30/2018 Q3 -- $573M $0.12 -- --
06/30/2018 Q2 -- $567M $0.02 -- --
03/31/2018 Q1 -- $558M $0.10 -- --
12/31/2017 Q4 -- $527.2M $0.09 -- --
09/30/2017 Q3 -- $556M $0.12 -- --
06/30/2017 Q2 -- $561M $0.09 -- --
03/31/2017 Q1 -- $431M $0.10 -- --
12/31/2016 Q4 -- $317.7M $0.09 -- --
09/30/2016 Q3 -- $215.3M $0.11 -- --
06/30/2016 Q2 -- $224.6M $0.10 -- --
03/31/2016 Q1 -- $238M $0.09 -- --
12/31/2015 Q4 -- $209.9M -$0.02 -- --
09/30/2015 Q3 -- $228.4M $2.75 -- --
06/30/2015 Q2 -- $215.6M $0.08 -- --
03/31/2015 Q1 -- $198.9M $0.02 -- --

Vitro SAB de CV Earnings Questions

  • How Much did Vitro SAB de CV Generate in Revenue Last Quarter?

    Vitro SAB de CV reported -$1.5B worth of top line sales in its most recent quarter.

  • Did Vitro SAB de CV Beat Earnings Last Quarter?

    Vitro SAB de CV announced earnings per share of $0.09 which represents a beat of analyst forecast a -- per share.

  • Is Vitro SAB de CV Profitable?

    Vitro SAB de CV reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Vitro SAB de CV EPS Next Year?

    Vitro SAB de CV's earnings are forecast to grow from $0.27 per share to -- per share next year representing an increase of --.

  • When is Vitro SAB de CV's Earnings Date?

    Currently, Vitro SAB de CV has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 16, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Target a Dividend King?
Is Target a Dividend King?

Popular retail giant Target Corporation (NYSE:TGT) has been in a…

Is COWZ ETF a Good Investment?
Is COWZ ETF a Good Investment?

There’s a reason even Warren Buffett advocates his heirs to…

3 Stocks Buffett Is Betting On
3 Stocks Buffett Is Betting On

Warren Buffett appeared to take a hard look at the…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 39x

Sell
46
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 112x

Sell
40
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
61
ITCI alert for Jan 14

Intra-Cellular Therapies [ITCI] is down 0.26% over the past day.

Sell
30
ESTA alert for Jan 14

Establishment Labs Holdings [ESTA] is down 1.51% over the past day.

Buy
72
DJT alert for Jan 14

Trump Media & Technology Group [DJT] is down 8.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock